• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconDrugs

Drugs

Page 29 of 30
FeaturesRegeneron vaults ahead of Amgen in race to market cholesterol drug
By ReutersJanuary 26, 2015
Los Angeles City Council Votes To Ban Medical Marijuana Dispensaries
RetailHigh stakes: How this marijuana company gained buzz in a budding market
By Entrepreneur and Ben GeierDecember 26, 2014
FedEx Reports Sharp Decline In Quarterly Profits
LeadershipThe war on drugs comes to Corporate America
By Chris MatthewsDecember 2, 2014
Images Of Over-The-Counter Medicines And Dietary Supplements By Japanese Drugmakers
FeaturesJapan’s Otsuka to buy U.S. drug maker Avanir for $3.5 billion
By Laura LorenzettiDecember 2, 2014
ArcelorMittal facility
FinanceMerck buys the rights to an experimental Ebola vaccine
By ReutersNovember 24, 2014
188066510
Features5 things that will kill you before Ebola does
By Verne KopytoffOctober 30, 2014
Prostitute, UK
FinanceHands off our hookers’ and dope dealers’ money, U.K. tells E.U.
By Geoffrey SmithOctober 24, 2014
SPAIN-ECONOMY-UNEMPLOYMENT
FinanceSpain gets a questionable GDP boost, thanks to drugs and prostitution
By Ian MountOctober 8, 2014
Berlin Hospital Prepares For Possible Ebola Cases
FeaturesDallas Ebola patient gets experimental drug
By TIMEOctober 7, 2014
Gambino Crime Family Arrest
LeadershipFortune 5: The Biggest Organized Crime Groups in the World
By Chris MatthewsSeptember 14, 2014
Roche FY Earnings Press Conference
FinanceRoche paying $8.3 billion for InterMune and its ‘breakthrough’ respiratory drug
By Laura LorenzettiAugust 25, 2014
FinancePfizer facing growing number of lawsuits over Lipitor side effects
By Laura LorenzettiAugust 8, 2014
LeadershipWhen corruption is good for the economy
By Chris MatthewsAugust 7, 2014
Finance
FinanceAbbvie rakes in profit as investors look for assurance on Shire deal
By Laura LorenzettiJuly 25, 2014
Bristol-Myers 2013 Earnings Forecast Beats Estimates
FeaturesBristol-Myers profits beat estimates as it readies new immuno-harnessing cancer drug
By Laura LorenzettiJuly 24, 2014
1...
  • 26
  • 27
  • 28
  • 29
  • 30
30
Most Popular
AI
A man let ChatGPT sell his home. It beat every agent's estimate by $100K—and closed in 5 daysAn image of a popular article
By Fortune EditorsMarch 21, 2026
Success
Covid gave us hybrid work. The Iran War might give us a four-day week—and this time, experts say it could stickAn image of a popular article
By Fortune EditorsMarch 21, 2026
Real Estate
Gen Z can’t afford a house. Some parents are choosing to fund their down payments over their college fundsAn image of a popular article
By Fortune EditorsMarch 20, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.